Answering to identified market needs in diabetes and obesity research and drug discovery, the new cell line launched by Euro Diagnostica is designed to address the needs of pharmaceutical- and biotechnology companies for the quantification of drug potency, and detection of neutralizing antibodies (NAbs).
|Scientific poster presenting performance data and product characteristics for the new iLite™ Insulin Assay Ready Cell line responsive to insulin.|
In this scientific poster Dr. Michael G. Tovey reports how assay-ready frozen iLite reporter gene cells eliminate the principal inconveniences of cell-based assays in general and provide the basis for the establishment of rapid, precise and highly specific assays for both the quantification of human insulin and neutralizing anti-insulin antibodies even in the presence of human serum.
It is also shown how the assay-ready frozen cells provide a means of quantifying insulin activity or neutralizing antibodies without the need for cell culture. A vial can simply be thawed and an assay can be carried out immediately.